Search research articles
Contact Us
Filters
Showing results (51-60 of 74) with videos related to
Page
of 8
Sort By:
Cancers
|
March 29, 2023
The First-In-Class Anti-AXL×CD3ε Pronectin™-Based Bispecific T-Cell Engager Is Active in Preclinical Models of Human Soft Tissue and Bone Sarcomas
Nicoletta Polerà, Antonia Mancuso, Caterina Riillo, et al.
Leukemia
|
March 1, 2018
Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity
Nicola Amodio, Maria Angelica Stamato, Giada Juli, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
March 26, 2023
TERRA G-quadruplex stabilization as a new therapeutic strategy for multiple myeloma
Francesca Scionti, Giada Juli, Roberta Rocca, et al.
Leukemia
|
August 19, 2018
miR-22 suppresses DNA ligase III addiction in multiple myeloma
Daniele Caracciolo, Maria Teresa Di Martino, Nicola Amodio, et al.
Journal of Clinical Medicine
|
April 26, 2025
Severe Hemodynamic Instability in a Young Pregnant Woman with Massive Pericardial Effusion and Pulmonary Embolism Secondary to Primary Mediastinal Non-Hodgkin's Lymphoma
Giuseppe Neri, Jessica Ielapi, Vincenzo Bosco, et al.
Journal of Translational Medicine
|
October 23, 2022
Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin
Daniele Caracciolo, Giada Juli, Caterina Riillo, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
December 30, 2015
Role of Chemotherapy and Allografting in the Treatment of Acute Lymphoblastic Leukemia
Luisa Giaccone, Ernesta Audisio, Benedetto Bruno, et al.
British Journal of Haematology
|
November 14, 2023
UMG1/CD3ε-bispecific T-cell engager redirects T-cell cytotoxicity against diffuse large B-cell lymphoma
Daniele Caracciolo, Nicoletta Polerà, Beatrice Belmonte, et al.
Hematological Oncology
|
March 16, 2026
UMG1 Defines a Targetable Subset of T-Cell Lymphomas and Enables Precision Immunotherapy With a First-in-Class CD3ε Bispecific Engager
Daniele Caracciolo, Carlo Gentile, Sara Squillacioti, et al.
Journal of Hematology & Oncology
|
March 23, 2019
Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma
Maria Cucè, Maria Eugenia Gallo Cantafio, Maria Anna Siciliano, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 74) with videos related to
Sort By:
Page
of 8
Cancers
|
March 29, 2023
The First-In-Class Anti-AXL×CD3ε Pronectin™-Based Bispecific T-Cell Engager Is Active in Preclinical Models of Human Soft Tissue and Bone Sarcomas
Nicoletta Polerà, Antonia Mancuso, Caterina Riillo, et al.
Leukemia
|
March 1, 2018
Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity
Nicola Amodio, Maria Angelica Stamato, Giada Juli, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
March 26, 2023
TERRA G-quadruplex stabilization as a new therapeutic strategy for multiple myeloma
Francesca Scionti, Giada Juli, Roberta Rocca, et al.
Leukemia
|
August 19, 2018
miR-22 suppresses DNA ligase III addiction in multiple myeloma
Daniele Caracciolo, Maria Teresa Di Martino, Nicola Amodio, et al.
Journal of Clinical Medicine
|
April 26, 2025
Severe Hemodynamic Instability in a Young Pregnant Woman with Massive Pericardial Effusion and Pulmonary Embolism Secondary to Primary Mediastinal Non-Hodgkin's Lymphoma
Giuseppe Neri, Jessica Ielapi, Vincenzo Bosco, et al.
Journal of Translational Medicine
|
October 23, 2022
Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin
Daniele Caracciolo, Giada Juli, Caterina Riillo, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
December 30, 2015
Role of Chemotherapy and Allografting in the Treatment of Acute Lymphoblastic Leukemia
Luisa Giaccone, Ernesta Audisio, Benedetto Bruno, et al.
British Journal of Haematology
|
November 14, 2023
UMG1/CD3ε-bispecific T-cell engager redirects T-cell cytotoxicity against diffuse large B-cell lymphoma
Daniele Caracciolo, Nicoletta Polerà, Beatrice Belmonte, et al.
Hematological Oncology
|
March 16, 2026
UMG1 Defines a Targetable Subset of T-Cell Lymphomas and Enables Precision Immunotherapy With a First-in-Class CD3ε Bispecific Engager
Daniele Caracciolo, Carlo Gentile, Sara Squillacioti, et al.
Journal of Hematology & Oncology
|
March 23, 2019
Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma
Maria Cucè, Maria Eugenia Gallo Cantafio, Maria Anna Siciliano, et al.
Page
of 8